Washington, Sept 21: Britney Spears has found a new ‘party’ pal in pop rival, Avril Lavigne.

The two met when Britney joined pals at Hollywood hotspot Hyde, and after hitting it off, they even shared a ride to another hotspot, Winston's, reports Contactmusic.

Avril and Britney’s partying comes just months after the former c criticized Spears for being too weedy to handle the demands of stardom.

Washington, Sept 21 : A new study has revealed that along with expanding waistlines, diets rich in rapidly-digested carbohydrates may also cause fatty liver, a condition that can lead to liver failure and death, a new study in mice has revealed.

If confirmed in humans, the findings suggest that fatty liver disease that is rampant among Americans as a by-product of the obesity epidemic may be avertable and can be treated through dietary changes.

Washington, Sept 21 : It seems that Britney Spears is the hot favourite for playing a role in a new sitcom opposite ‘Friends’ star Matthew Perry.

Perry plays a businessman who asks a girl to pretend to be his wife to give his career a boost.

According to reports, NBC TV network heads want Spears to play the girl’s role.

A TV source said that Spears has the appeal that connects with the audience.

Washington, Sept 21 : Actress Katherine Heigl will be bringing ‘Lost & Found’ to the bring screen after securing the film rights to the bestselling dramatic novel.

Though it’s not as yet known whether Heigl will star in the movie, she will be producing it along with her mother and producing partner Nancy Heigl through her new production banner Abishag.

The book, by Jacqueline Sheehan, is based on a widowed psychologist who moves to a remote Maine island and works in an animal hospital after her husband dies, reports Variety.

Washington, September 21 : A smart particle insulin release system that detects spikes in glucose and blood sugar levels, and releases insulin to counteract them has shown promising results in feasibility tests on animal models.

Researchers at The University of Texas School of Health Information Sciences at Houston have announced the findings of the pre-clinical test in the International Journal of Nanomedicine.